EP Patent

EP3067050A1 — Transdermal therapeutic system with an overtape comprising two adhesive layers

Assigned to Luye Pharma AG · Expires 2016-09-14 · 10y expired

What this patent protects

The present invention relates to a transdermal therapeutic system for administration of an active ingredient and a process for the preparation thereof. The transdermal therapeutic system comprises an overtape with two adhesive layers.

USPTO Abstract

The present invention relates to a transdermal therapeutic system for administration of an active ingredient and a process for the preparation thereof. The transdermal therapeutic system comprises an overtape with two adhesive layers.

Drugs covered by this patent

Patent Metadata

Patent number: EP3067050A1
Jurisdiction: EP
Classification: —
Expires: 2016-09-14
Drug substance claim: No
Drug product claim: No
Assignee: Luye Pharma AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.